LIke ThisLIke ThisLIke This

Stephen  Sallan, MD

Stephen Sallan, MD
Research Center:
Dana-Farber/Boston Children’s Cancer and Blood Disorders Center
Medicine Research
Hematology/Oncology Research
Hospital Title:
Chief of Staff Emeritus, Dana-Farber Cancer Institute
Academic Title:
Professor of Pediatrics, Harvard Medical School
Research Focus Area:
Acute lymphoblastic anemia
Contact Via Email
Send an email to SendYour Name*Your Email Address*Subject*Comments*

Research Overview

Stephen Sallan's laboratory and clinical research focuses on the genetic heterogeneity and treatment of the most common malignancy of childhood, acute lymphoblastic leukemia (ALL). The researcher strives to understand the reasons for disease recurrence and drug resistance, develop new, more specific therapies, especially for the 20% of children whose leukemia is not cured by current therapies, and conduct all such research in the context of diminishing the toxicity of treatment. Current endeavors expand our investigations to adolescents and young adults with ALL and also extend the laboratory discoveries to other leukemias and lymphomas.

About Stephen Sallan

Dr. Sallan received his MD from Wayne State University School of Medicine. He completed residencies in pediatrics at the Boston Floating Hospital, Children's Hospital of Philadelphia, and the Hospital for Sick Children, London and a fellowship in pediatric oncology at Children's Hospital Boston and Dana-Farber Cancer Institute.

Dr Sallan received the Distinguished Alumni Award, Wayne State University School of Medicine, the James Carreras Prize for International Pediatrician of the Year, and the Boston Red Sox Biomedical All Star Award.

LIke ThisLIke ThisLIke This


Dana-Farber/Boston Children’s Cancer and Blood Disorders Center

Dana-Farber/Boston Children's Cancer and Blood Disorders Center is one of the top research centers in the world for pediatric cancers and blood diseases. It brings together laboratory scientists and clinical researchers from Dana-Farber Cancer Institute and Boston Children’s Hospital in a single program. We investigate pediatric cancers and non-malignant blood disorders from every angle—from examining cells under the microscope to tracking the effectiveness of current drug regimens using the most advanced molecular methods—so that we can create better treatments for children seen here and around the world.

Learn more